![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
PV Schoenlein, DW Shen, JT Barrett, I Pastan and MM Gottesman
Laboratory of Cell Biology, National Institutes of Health, National Cancer Institute, Bethesda, Maryland 20892.
This study characterizes amplified structures carrying the human multidrug resistance (MDR) genes in colchicine-selected multidrug resistant KB cell lines and strongly supports a model of gene amplification in which small circular extrachromosomal DNA elements generated from contiguous chromosomal DNA regions multimerize to form cytologically detectable double minute chromosomes (DMs). The human MDR1 gene encodes the 170-kDa P-glycoprotein, which is a plasma membrane pump for many structurally unrelated chemotherapeutic drugs. MDR1 and its homolog, MDR2, undergo amplification when KB cells are subjected to stepwise selection in increasing concentrations of colchicine. The structure of the amplification unit at each step of drug selection was characterized using both high-voltage gel electrophoresis and pulsed-field gel electrophoresis (PFGE) techniques. An 890-kb submicroscopic extrachromosomal circular DNA element carrying the MDR1 and MDR2 genes was detected in cell line KB-ChR-8-5-11, the earliest step in drug selection in which conventional Southern/hybridization analyses detected MDR gene amplification. When KB-ChR-8-5-11 was subjected to stepwise increases in colchicine, this circular DNA element dimerized as detected by PFGE with and without digestion with Not 1, which linearizes the 890-kb amplicon. This dimerization process, which also occurred at the next step of colchicine selection, resulted in the formation of cytologically detectable DMs revealed by analysis of Giemsa-stained metaphase spreads.
This article has been cited by other articles:
|
|
 |
|
  N. Vogt, S.-H. Lefevre, F. Apiou, A.-M. Dutrillaux, A. Cor, P. Leuraud, M.-F. Poupon, B. Dutrillaux, M. Debatisse, and B. Malfoy Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas PNAS, August 3, 2004; 101(31): 11368 - 11373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shimizu, T. Hashizume, K. Shingaki, and J.-k. Kawamoto Amplification of Plasmids Containing a Mammalian Replication Initiation Region Is Mediated by Controllable Conflict between Replication and Transcription Cancer Res., September 1, 2003; 63(17): 5281 - 5290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Rizwana and P. Hahn CpG methylation reduces genomic instability J. Cell Sci., January 12, 1999; 112(24): 4513 - 4519. [Abstract] [PDF]
|
|
|
|
 |
|
 K Torigoe, S Sato, H Kusaba, K Kohno, M Kuwano, K Okumura, E D Green, L C Tsui, S W Scherer, and D Schlessinger A YAC-based contig of 1.5 Mb spanning the human multidrug resistance gene region and delineating the amplification unit in three human multidrug-resistant cell lines. Genome Res., October 1, 1995; 5(3): 233 - 244. [Abstract] [PDF]
|
|
|
|
|
|
S. Hoffmeyer, O. Burk, O. von Richter, H. P. Arnold, J. Brockmoller, A. Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum, et al. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo PNAS, March 28, 2000; 97(7): 3473 - 3478. [Abstract] [Full Text] [PDF]
|
|
